Level 42 AI

Startup life is hard at times, so awards like this one certainly makes you feel more energized!

Level 42 AI, Inc vibrome™ biosignatures framework is a Center for Advancing Innovation Global Health Innovation Winner The human body resembles a musical orchestra. The real-time “noise” generated by the human body is an underexplored data source for biomarker discovery.

We are very proud and excited to be among this group of highly innovative companies!

NEW: 12 have been selected for the Spring 2023 cohort of FAST California! After receiving a record number of applicants, this is our LARGEST cohort to date!
🚀BCN Biosciences
🚀Flexperc Medical
🚀GelSana Therapeutics, Inc.
🚀Immunova Therapeutics
🚀Jaan Biotherapeutics L.L.C.
🚀JAL Therapeutics
🚀Level 42 AI, Inc.
🚀Minutia
🚀ParaMag Biosciences
🚀Scopi Medical
🚀Siege Pharmaceuticals
🚀Synthis Therapeutics

Each will be matched with a custom advisory team based on their unique business and commercialization goals. In its 10th year, FAST has helped 100+ innovative startups perfect their business plans and commercialization strategies! LEARN MORE: https://bit.ly/3ZgzFj4

Level 42 AI is delighted to be part of Operation Warp Speed, collaborating with the Geneva Foundation and 4D3Bio https://lnkd.in/eYgeT8KT, to showcase how and health information hidden in can be leveraged to help the world turn the corner on the and prepare for the next pandemic in an and way.

U.S. Military Collaboration Using Breathalyzer Technology to Detect SARS-CoV-2 - Geneva USA Researchers with The Geneva Foundation under the USU-4DBio3 Center for Biotechnology (4D Bio3) are working to develop adaptable tools to detect the presence of SARS-CoV-2 and other dangerous pathogens in less than three minutes using breathalyzer technology and detection through audible sound.

In the news:

See what startups participated in Berkeley SkyDeck Demo Day In-person demo days are back, and these startups are vying for investors' attention.

Enjoyed the Axios virtual-event today “A conversation on COVID-19 testing post vaccines”. Some of the world’s foremost experts discussed the current state of testing for COVID-19 and what we need to do to ensure our society safely gets back to work, school, and life.

https://www.axios.com/rapid-covid-testing-bf40070e-8b09-4778-a17e-72a72023f2a9.html

Jennifer Nuzzo from Johns Hopkins discussed the need for sufficient disease surveillance across regions and populations
Michael Mina from Harvard suggested the need for entrance screening for schools and offices – this will reduce spread of infection by 90%
Deepak Nath from Siemens highlighted that COVID-19 will be with us for a while, he stated 25% of the US population are kids and they are not eligible for vaccination till the end of 2021.
Michael Osterholm University of Minnesota said we need to continue to make testing readily available so we can ensure schools and travel is safe

All experts agree that:

COVID-19 variants are a problem and will persist
1 - We Need More Testing!
2 - Testing should be here to stay; must be easy and affordable
3 - Vaccine passports ARE not an equitable solution
4 - Must increase testing for vaccine durability

Level42 AI helps solve the testing issue as it’s Impulse dCoder™ provides a cost-effective, fast, accurate, non-contact COVID-19 screening solution that can be placed at points of entry at schools, office buildings, airports and beyond.

Public health experts: Rapid COVID-19 tests are the next frontier to fight the pandemic "We need rapid tests that are ubiquitous, that we can use in lots of different places"